These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 13842895)

  • 21. [MICROBIOLOGICAL STUDIES ON TRIACETYLOLEANDOMYCIN].
    VAKULENKO NA
    Antibiotiki; 1964 Nov; 9():1017-20. PubMed ID: 14320473
    [No Abstract]   [Full Text] [Related]  

  • 22. Triacetyloleandomycin in the treatment of severe infections in infants and children.
    OZYAZICI A; COHEN HJ; PRIGOT A
    Q Rev Pediatr; 1960; 15():102-9. PubMed ID: 14429613
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of otitis media with an oral antibiotic (triacetyloleandomycin).
    FOWLER PD
    Practitioner; 1961 Nov; 187():684-8. PubMed ID: 13894346
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of dysentery caused by antibiotic-resistant strains with triacetyloleandomycin (Taocin)].
    TOTANI T; YAMANAKA T; IIDA M; INAMURA Y
    Nihon Densenbyo Gakkai Zasshi; 1962 Jul; 36():139-51. PubMed ID: 13922102
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood concentrations of oleandomycin after administration of triacetyloleandomycin].
    Caliò R; Pezzi R; Renzini G
    Gazz Int Med Chir; 1964 Dec; 68(24):Suppl:2540-7. PubMed ID: 5294274
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trial of triacetyloleandomycin in the treatment of acne conglobata, nummular dermatitis and other resistant coccogenous dermatologic infections.
    KLESSENS NF
    Antibiot Chemother (Northfield); 1962 Aug; 12():551-3. PubMed ID: 14456900
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin.
    GILBERT FI
    JAMA; 1962 Dec; 182():1048-50. PubMed ID: 13947810
    [No Abstract]   [Full Text] [Related]  

  • 28. Acne vulgaris treated with triacetyloleandomycin.
    PARKER W
    Med Times; 1962 Mar; 90():310-2. PubMed ID: 14483935
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid diagnostic susceptibility tests and prompt therapy with triacetyloleandomycin.
    RIPBERGER FM; ANDERSON RH; PALMER RE
    Antibiotic Med Clin Ther (New York); 1959 Nov; 6():662-9. PubMed ID: 14437535
    [No Abstract]   [Full Text] [Related]  

  • 30. Triacetyl-oleandomycin in the treatment of upper and lower respiratory tract infections (report on a multicenter study).
    Van Cauwenberghe P
    Quad Antibiot; 1975 Jun; ():122-40. PubMed ID: 1088733
    [No Abstract]   [Full Text] [Related]  

  • 31. Triacetyloleandomycin, a two and one-half year study of in vitro susceptibility testing of antibiotic-resistant staphylococci.
    ENGLISH AR; FINK FC
    Antibiot Chemother (Northfield); 1961 Oct; 11():648-51. PubMed ID: 13890285
    [No Abstract]   [Full Text] [Related]  

  • 32. Triacetyloleandomycin: further observations on the treatment of acne and pyodermas.
    OLANSKY S; MCCORMICK GE
    Antibiot Annu; 1959-1960; 7():652-6. PubMed ID: 14428587
    [No Abstract]   [Full Text] [Related]  

  • 33. [Triacetyloleandomycin (P.A. 777)].
    WAREMBOURG H; DESMET G; LEKIEFFRE J
    Lille Med; 1961 Mar; 6():238-43. PubMed ID: 13783140
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness of triacetyloleandomycin: in vitro and in vivo studies.
    WERTHAMER S; PECORA CL
    Antibiotic Med Clin Ther (New York); 1960 Sep; 7():560-5. PubMed ID: 13844064
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of triacetyloleandomycin in the treatment of pustular and cystic acne: a double blind study.
    MORGINSON WJ; ESKELSON YD
    Antibiot Annu; 1959-1960; 7():657-9. PubMed ID: 14424141
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of granuloma inguinale with triacetyloleandomycin. Report of a case.
    KERDEL-VEGAS F; CONVIT J; SOTO JM
    Arch Dermatol; 1961 Aug; 84():248-55. PubMed ID: 13752597
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of treatment with spiramycin in bacterial infections of the respiratory tract].
    WINTER H
    Med Klin; 1960 Dec; 55():2286-8. PubMed ID: 15445615
    [No Abstract]   [Full Text] [Related]  

  • 38. Some in vitro susceptibility results with triacetyloleandomycin.
    HORTON GE; DAVIS JW
    Antibiot Chemother (Northfield); 1962 Jun; 12():404-10. PubMed ID: 14449073
    [No Abstract]   [Full Text] [Related]  

  • 39. Triacetyloleandomycin (TAO)-its value in acne and certain pyogenic skin eruptions. J.
    LOVEMAN AB; HAMMOND K
    J Ky Med Assoc; 1959 Dec; 57():1507-10. PubMed ID: 13853712
    [No Abstract]   [Full Text] [Related]  

  • 40. [On 47 cases of acute otitis media and their antral and mastoid complications treated by triacetyloleandomycin].
    BONNEFOUS G
    Sem Hop Ther Paris; 1961 Oct; 37():744-7. PubMed ID: 13871032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.